Gilead Sciences (GILD) Q4 Revenue Tops Views, Offers Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $149.61 --0%
Revenue Growth %: -0.3%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: -0.3%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $1.78, $0.11 better than the analyst estimate of $1.67. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.74 billion.
GUIDANCE:
Gilead Sciences sees FY2018 revenue of $20-21 billion, versus the consensus of $21.97 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
- C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance
- PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
